{
    "organizations": [],
    "uuid": "7df3df6a9300de027d873ff7f0e178f22562c1dc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aequus-and-ehave-enter-into-collab/brief-aequus-and-ehave-enter-into-collaboration-agreement-idUSASB0C8RU",
    "ord_in_thread": 0,
    "title": "BRIEF-Aequus And Ehave Enter Into Collaboration Agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Aequus Pharmaceuticals Inc:\n* AEQUUS AND EHAVE ENTER INTO COLLABORATION AGREEMENT FOR COMPREHENSIVE PATIENT DATA MANAGEMENT IN CLINICAL TRIALS OF MEDICAL CANNABIS\n* AEQUUS PHARMACEUTICALS INC - ‍TERMS OF AGREEMENT ARE SIMILAR TO THAT OF ORIGINAL LETTER OF INTENT​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-05T21:50:00.000+02:00",
    "crawled": "2018-03-06T22:19:32.053+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "aequus",
        "pharmaceutical",
        "inc",
        "aequus",
        "ehave",
        "enter",
        "collaboration",
        "agreement",
        "comprehensive",
        "patient",
        "data",
        "management",
        "clinical",
        "trial",
        "medical",
        "cannabis",
        "aequus",
        "pharmaceutical",
        "inc",
        "agreement",
        "similar",
        "original",
        "letter",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}